ATE315552T1 - 5-((6-(2-fluorbenzyl)oxy-2-naphtyl)methyl)- thiazolid in-2,4-dion kristallen - Google Patents

5-((6-(2-fluorbenzyl)oxy-2-naphtyl)methyl)- thiazolid in-2,4-dion kristallen

Info

Publication number
ATE315552T1
ATE315552T1 AT99972628T AT99972628T ATE315552T1 AT E315552 T1 ATE315552 T1 AT E315552T1 AT 99972628 T AT99972628 T AT 99972628T AT 99972628 T AT99972628 T AT 99972628T AT E315552 T1 ATE315552 T1 AT E315552T1
Authority
AT
Austria
Prior art keywords
naphtyl
oxy
methyl
fluorbenzyl
thiazolide
Prior art date
Application number
AT99972628T
Other languages
English (en)
Inventor
Takayuki Oe
Hiroaki Ueno
Akira Maruyama
Katsuhiko Masuda
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE315552T1 publication Critical patent/ATE315552T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
AT99972628T 1998-11-20 1999-11-19 5-((6-(2-fluorbenzyl)oxy-2-naphtyl)methyl)- thiazolid in-2,4-dion kristallen ATE315552T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33054698 1998-11-20

Publications (1)

Publication Number Publication Date
ATE315552T1 true ATE315552T1 (de) 2006-02-15

Family

ID=18233859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972628T ATE315552T1 (de) 1998-11-20 1999-11-19 5-((6-(2-fluorbenzyl)oxy-2-naphtyl)methyl)- thiazolid in-2,4-dion kristallen

Country Status (23)

Country Link
US (3) US6541493B1 (de)
EP (1) EP1131310B1 (de)
JP (1) JP3784001B2 (de)
KR (1) KR100652326B1 (de)
CN (1) CN1326449A (de)
AT (1) ATE315552T1 (de)
AU (1) AU1185100A (de)
BR (1) BR9916795A (de)
CA (1) CA2351727C (de)
CZ (1) CZ20011763A3 (de)
DE (1) DE69929476T2 (de)
ES (1) ES2257104T3 (de)
HU (1) HUP0104139A3 (de)
ID (1) ID30064A (de)
IL (1) IL143177A0 (de)
NO (1) NO20012444L (de)
NZ (1) NZ512429A (de)
PL (1) PL348502A1 (de)
PT (1) PT1131310E (de)
TR (4) TR200101901T2 (de)
TW (2) TWI250156B (de)
WO (1) WO2000031055A1 (de)
ZA (1) ZA200104081B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2351727C (en) * 1998-11-20 2008-09-23 Mitsubishi Chemical Corporation Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
HUP0203280A3 (en) * 1999-11-19 2003-07-28 Ortho Mcneil Pharm Inc Solid state forms of 5-[[6-[(2-fluorphenyl)methoxy]-2-naphtalenyl]methyl]-2,4-thiazolidinedione, process for their preparation and pharmaceutical compositions containing them
CN100577175C (zh) * 2001-04-04 2010-01-06 奥索-麦克尼尔药品公司 包括葡萄糖重吸收抑制剂和ppar调节剂的联合疗法
WO2007049050A2 (en) * 2005-10-27 2007-05-03 Heptahelix Ab Modulators of gpr40 for the treatment of diabetes
US8222273B2 (en) * 2008-02-04 2012-07-17 Pfizer Limited Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2845743B2 (ja) 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP4023697B2 (ja) 1996-11-14 2007-12-19 三菱化学株式会社 ナフタレン誘導体の製造方法
CA2351727C (en) * 1998-11-20 2008-09-23 Mitsubishi Chemical Corporation Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Also Published As

Publication number Publication date
TR200202103T2 (tr) 2002-11-21
CA2351727A1 (en) 2000-06-02
IL143177A0 (en) 2002-04-21
TR200202109T2 (tr) 2002-11-21
US6541493B1 (en) 2003-04-01
WO2000031055A1 (en) 2000-06-02
EP1131310A1 (de) 2001-09-12
ES2257104T3 (es) 2006-07-16
JP2002530392A (ja) 2002-09-17
ID30064A (id) 2001-11-01
ZA200104081B (en) 2002-05-20
NZ512429A (en) 2003-11-28
TR200202110T2 (tr) 2002-10-21
CZ20011763A3 (cs) 2001-10-17
AU1185100A (en) 2000-06-13
HUP0104139A2 (hu) 2002-03-28
TWI272944B (en) 2007-02-11
US20060149075A1 (en) 2006-07-06
KR20010101033A (ko) 2001-11-14
NO20012444L (no) 2001-07-18
CA2351727C (en) 2008-09-23
NO20012444D0 (no) 2001-05-18
DE69929476T2 (de) 2006-09-14
US20030158241A1 (en) 2003-08-21
TW200613291A (en) 2006-05-01
DE69929476D1 (de) 2006-04-06
KR100652326B1 (ko) 2006-11-29
PT1131310E (pt) 2006-05-31
CN1326449A (zh) 2001-12-12
TWI250156B (en) 2006-03-01
BR9916795A (pt) 2002-04-09
JP3784001B2 (ja) 2006-06-07
PL348502A1 (en) 2002-05-20
TR200101901T2 (tr) 2002-04-22
EP1131310B1 (de) 2006-01-11
HUP0104139A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
DK1203766T3 (da) Carboxylisyrederivater, der hæmmer bindingen af integriner til deres receptorer
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
FI933804A (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2H-indol-2-onkhydroklorid
EA200000656A1 (ru) Замещенное производное тиазолидиндиона, способ его получения и его фармацевтическое применение
MY103979A (en) Hypoglycemic thiazolidinedione derivatives.
ATE420876T1 (de) Propansäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
HUP0203841A3 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
FI101296B1 (fi) Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi
JO2239B1 (en) Method for preparing benzothophen derivatives
HRP20010772B1 (en) Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt
IE44845L (en) Pyrimidone and thiopyrimidone derivatives
EA200000655A1 (ru) Гидрат соли малеиновой кислоты 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона
ATE315552T1 (de) 5-((6-(2-fluorbenzyl)oxy-2-naphtyl)methyl)- thiazolid in-2,4-dion kristallen
UY25304A1 (es) Forma hidratada de maleato de rosiglitazona
TR200002790T2 (tr) 5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip
EA200101101A1 (ru) Новый фармацевтический препарат
EA200101102A1 (ru) Новый фармацевтический препарат
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
JPS57206683A (en) Pyrimidone salt, manufacture and medicinal composition containing same
HUP9801914A2 (hu) 2-[2-(Heteroaril-oxi-metil)-fenil]-krotonátok, előállításuk, a vegyületeket hatóanyagként tartalmazó peszticid és fungicid készítmények és alkalmazásuk
ES8304995A1 (es) "procedimiento para la preparacion de nuevas cefalosporinas".
GR81392B (de)
ECSP003434A (es) Nuevos compuestos
FI972528A0 (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131310

Country of ref document: EP

REN Ceased due to non-payment of the annual fee